Typhoid Fever: Complete ICD-11 Coding Guide (1A07)

1. Introduction

Typhoid fever is a potentially serious systemic bacterial infection caused by the bacterium Salmonella enterica serovar Typhi (Salmonella Typhi). This disease represents an important global public health problem, especially in regions with inadequate sanitation and limited access to potable water. Unlike other intestinal infections, typhoid fever is characterized by a striking systemic presentation, with sustained fever, neurological symptoms, and manifestations that extend far beyond the gastrointestinal tract.

Transmission occurs primarily through the fecal-oral route, via ingestion of water or food contaminated with feces from infected individuals or asymptomatic carriers. The disease presents a typical incubation period of 6 to 30 days, with insidious onset of symptoms that progress gradually over weeks if not treated appropriately. It is estimated that millions of cases occur annually worldwide, with mortality rates that can reach 10-30% in untreated patients, but which fall to 1-4% with appropriate antibiotic treatment.

Correct coding of typhoid fever in the ICD-11 system is fundamental for various aspects of medical practice and health management. It enables appropriate epidemiological monitoring, facilitating the identification of outbreaks and endemic areas; ensures appropriate reimbursement for services rendered; guides specific treatment protocols; aids in the implementation of public health measures; and contributes to research on the disease and development of prevention strategies, including vaccination programs in at-risk areas.

2. Correct ICD-11 Code

Code: 1A07

Description: Typhoid fever

Parent category: Bacterial intestinal infections

Official definition: Acute systemic febrile infection caused by Salmonella Typhi, with insidious onset of sustained fever, severe headache, malaise, anorexia, relative bradycardia, splenomegaly, nonproductive cough in the initial phase of the disease, rose spots on the trunk in 25% of patients with white skin, and constipation more frequent than diarrhea in adults.

This code should be applied when there is laboratory confirmation or strong clinical-epidemiological suspicion of Salmonella Typhi infection. The classification in ICD-11 maintains typhoid fever as a distinct entity within bacterial intestinal infections, recognizing its unique characteristics and epidemiological importance. Code 1A07 differs from other non-typhoidal salmonellosis, which have separate coding due to significant differences in clinical presentation, severity, and therapeutic approach.

The hierarchical structure of ICD-11 positions typhoid fever within the chapter of infectious diseases, specifically in the group of bacterial intestinal infections, reflecting both the route of transmission and the etiological agent. This organization facilitates navigation in the coding system and helps professionals quickly locate the appropriate code when considering the differential diagnosis of gastrointestinal and febrile infections.

3. When to Use This Code

The code 1A07 should be used in specific clinical situations that characterize typhoid fever. Below, we present detailed practical scenarios:

Scenario 1: Sustained fever with laboratory confirmation Patient presenting with progressive fever for 7-10 days, starting with gradually ascending temperature reaching 39-40°C, accompanied by intense frontal headache, generalized malaise, and anorexia. The complete blood count reveals leukopenia with left shift, and blood culture confirms growth of Salmonella Typhi. In this case, code 1A07 is absolutely appropriate, as there is definitive microbiological confirmation associated with compatible clinical presentation.

Scenario 2: Characteristic clinical presentation in endemic area Individual residing in or recent traveler from an area with known transmission of typhoid fever, presenting with continuous fever for two weeks, relative bradycardia (pulse not proportionally increased to fever), palpable splenomegaly on physical examination, intestinal constipation, and appearance of rose spots (typhoid roseola) on the trunk and abdomen. Even while awaiting laboratory confirmation, code 1A07 can be used based on typical clinical presentation and epidemiological context.

Scenario 3: Complications of typhoid fever Patient with confirmed diagnosis of typhoid fever who develops complications such as intestinal perforation, gastrointestinal hemorrhage, or typhoid encephalopathy. Code 1A07 should be used as the principal diagnosis and may be supplemented with additional codes for specific complications when necessary for complete documentation.

Scenario 4: Relapse after initial treatment Patient previously treated for typhoid fever who presents with return of febrile symptoms, headache, and malaise 1-3 weeks after completion of antibiotic treatment. Relapses occur in approximately 10-20% of cases and should be coded again as 1A07, as they represent reactivation of the same infection.

Scenario 5: Symptomatic chronic carrier Individual who continues to shed Salmonella Typhi in feces or urine for more than one year after acute infection and presents with related clinical manifestations. Code 1A07 is appropriate for documenting this condition, especially when there is a need for prolonged treatment or investigation of biliary focus.

Scenario 6: Retrospective diagnosis with positive serology Patient with clinical history suggestive of previously undiagnosed prolonged febrile illness who presents with documented seroconversion with elevated titers of anti-O and anti-H antibodies to Salmonella Typhi (Widal reaction or more specific tests). When the clinical-laboratory context confirms recent infection, code 1A07 should be applied.

4. When NOT to Use This Code

It is essential to distinguish typhoid fever from other conditions that may present with similar clinical manifestations but require different coding:

Paratyphoid fever: Caused by Salmonella Paratyphi A, B, or C, it typically presents with a milder clinical picture than typhoid fever, with shorter duration and fewer complications. This condition has a separate specific code (1A08) and should not be coded as 1A07, even if clinical differentiation is difficult without laboratory confirmation of the specific serotype.

Non-typhoidal salmonellosis: Infections by other Salmonella serovars (such as S. Enteritidis or S. Typhimurium) typically cause self-limited acute gastroenteritis, with watery or bloody diarrhea, vomiting, short-duration fever, and abdominal cramping. They rarely cause bacteremia or prolonged systemic disease in immunocompetent individuals. These infections require different coding and should not use code 1A07.

Other causes of prolonged fever: Conditions such as malaria, dengue, brucellosis, disseminated tuberculosis, bacterial endocarditis, lymphomas, and other neoplasms may present with sustained fever and systemic symptoms. Appropriate laboratory investigation is essential to differentiate these conditions from typhoid fever before applying code 1A07.

Shigella infections: Although they cause bacterial dysentery with fever, Shigella infections are characterized by bloody diarrhea with mucus, tenesmus, and intense abdominal cramping, differing significantly from the clinical pattern of typhoid fever. They use code 1A02.

Cholera and Vibrio infections: These infections manifest with profuse watery diarrhea, rapid dehydration, and rarely significant fever, being clearly distinct from typhoid fever. They require codes 1A00 and 1A01, respectively.

Code 1A07 should also not be used for asymptomatic carriers who do not present with active clinical manifestations, unless there is a specific need to document the carrier status for epidemiological or public health purposes.

5. Coding Step by Step

Step 1: Assess diagnostic criteria

The diagnosis of typhoid fever is based on the combination of clinical manifestations, epidemiological context, and laboratory confirmation. Clinically, seek the characteristic pattern: fever with insidious onset that increases progressively in a "stepladder" pattern, reaching 39-40°C and remaining elevated for weeks if untreated; persistent and intense frontal headache; relative bradycardia (pulse slower than expected for the degree of fever); profound malaise and prostration; marked anorexia; alterations in bowel habits, with constipation more common in adults and possible diarrhea in children.

On physical examination, look for splenomegaly (present in approximately half of cases), hepatomegaly, abdominal distension with diffuse tenderness, and typhoid rosettes (rose-colored macules of 2-4 mm on the trunk and abdomen, more visible in fair skin, present in approximately 25% of cases).

Laboratory confirmation is fundamental and can be obtained through: blood culture (gold standard, positive in 40-80% of cases in the first week); stool culture or urine culture (more positive after the first week); bone marrow culture (greater sensitivity, but rarely performed); serological tests such as Widal (less specific, require careful interpretation); and molecular methods such as PCR (when available, offer rapid and specific diagnosis).

Step 2: Check specifiers

Assess the severity of clinical presentation. Mild cases present with fever and systemic symptoms without complications; moderate cases involve significant prostration, marked gastrointestinal symptoms, and need for hospitalization; severe cases include complications such as intestinal perforation, gastrointestinal hemorrhage, encephalopathy, myocarditis, or septic shock.

Determine the phase of disease: first week (rising fever, nonspecific symptoms, dry cough); second week (sustained fever, maximum prostration, possible appearance of rosettes, splenomegaly); third week (possible improvement or development of complications); convalescent phase (gradual resolution, but risk of relapse).

Identify whether there are associated complications that may require additional coding: intestinal perforation (usually in the terminal ileum), gastrointestinal hemorrhage, encephalopathy (confusion, delirium, stupor), myocarditis, cholecystitis, osteomyelitis, or other focal manifestations.

Step 3: Differentiate from other codes

1A00 (Cholera): Characterized by profuse watery diarrhea of "rice water" type, rapid and severe dehydration, vomiting, muscle cramps, and absence of significant fever. Typhoid fever presents with sustained high fever as a central manifestation, constipation more common than diarrhea in adults, and prolonged course of weeks.

1A01 (Intestinal infection by other bacteria of the genus Vibrio): Causes acute gastroenteritis with watery diarrhea, short-duration symptoms (days), frequently associated with seafood consumption. It differs from typhoid fever by the absence of prolonged fever, less pronounced systemic symptoms, and rapid resolution.

1A02 (Intestinal infections by Shigella): Manifests with acute dysentery (bloody diarrhea with mucus), intense rectal tenesmus, severe abdominal cramps, fever usually of short duration, and symptoms limited to the gastrointestinal tract. Typhoid fever presents with predominance of systemic manifestations over gastrointestinal ones, more frequent constipation, and prolonged clinical course.

Step 4: Required documentation

For appropriate coding of code 1A07, medical documentation must include:

Mandatory checklist:

Detailed description of fever pattern (duration, intensity, characteristics)
Associated systemic symptoms (headache, malaise, anorexia)
Physical examination findings (splenomegaly, rosettes, relative bradycardia)
Alterations in bowel habits (constipation or diarrhea)
Epidemiological context (recent travel, known exposure, endemic area)
Laboratory test results (complete blood count, cultures, serology)
Microbiological confirmation when available (specify method and result)
Complications if present
Treatment instituted
Clinical course

The record must be sufficiently detailed to justify the diagnosis and coding, allowing for subsequent audit and contributing to reliable epidemiological data.

6. Complete Practical Example

Clinical Case

A 28-year-old male patient, a teacher, seeks medical care with a complaint of persistent fever for 12 days. He reports that the fever started gradually, with progressively rising temperature, currently reaching 39-40°C daily, without significant periods of apyrexia. He associates intense and continuous frontal headache, generalized malaise with significant prostration, marked anorexia with estimated weight loss of 4 kg during the period, and intestinal constipation for 5 days.

In the epidemiological history, he mentions having returned from travel to a region with poor sanitation 3 weeks ago, where he consumed food from street vendors and untreated water. He denies diarrhea, significant vomiting, or other important gastrointestinal symptoms. He reports dry cough at the beginning of the condition, already resolved.

On physical examination: prostrate patient, pale, febrile (axillary temperature 39.5°C), heart rate of 88 bpm (relative bradycardia for the degree of fever). Pale mucous membranes, without signs of dehydration. Cardiovascular system without significant abnormalities beyond relative bradycardia. Respiratory system without abnormalities. Distended abdomen, diffusely tender on deep palpation, without signs of peritoneal irritation, liver palpable 2 cm below the right costal margin, spleen palpable 3 cm below the left costal margin. Presence of small rose-colored spots on the trunk and upper abdomen, approximately 2-3 mm in diameter. No focal neurological signs, but patient presents with slowed thinking and some apathy.

Laboratory tests requested revealed: complete blood count with leukopenia (3,200 leukocytes/mm³), mild anemia (hemoglobin 11.2 g/dL), normal platelets; liver function tests with discrete elevation of transaminases; blood culture collected before initiation of antibiotics, with positive result after 48 hours for Salmonella enterica serovar Typhi sensitive to tested antibiotics.

Step-by-Step Coding

Analysis of criteria:

The patient presents all classic elements of typhoid fever: sustained fever of insidious onset with progressive pattern, marked headache, significant malaise and prostration, anorexia with weight loss, documented relative bradycardia, splenomegaly on physical examination, intestinal constipation (typical pattern in adults), rose-colored spots on the trunk (typhoid roseolas), and epidemiological context compatible with exposure in a risk area.

Laboratory confirmation by positive blood culture for Salmonella Typhi establishes the definitive diagnosis. Additional laboratory findings (leukopenia, elevation of transaminases) are compatible with the condition. The incubation period of approximately 2-3 weeks after exposure is within the expected range.

Code chosen: 1A07 - Typhoid fever

Complete justification:

The code 1A07 is absolutely appropriate in this case because there is unequivocal microbiological confirmation of infection by Salmonella Typhi associated with characteristic clinical presentation. The prolonged febrile condition with sustained pattern, prominent systemic manifestations, specific findings on physical examination (relative bradycardia, splenomegaly, typhoid roseolas), and epidemiological context converge toward the diagnosis of typhoid fever.

Differentiation from other bacterial intestinal infections is clear: there is no profuse diarrhea as in cholera, no dysentery as in Shigella infections, and the prolonged systemic presentation differs from self-limited acute gastroenteritis caused by other pathogens. Confirmation of the Typhi serovar definitively excludes paratyphoid fever (code 1A08).

Complementary codes:

In this specific case, there is no need for additional codes, as the patient does not present complications requiring separate coding. If there were development of intestinal perforation, gastrointestinal hemorrhage, or other complications, additional codes would be appropriate to completely document the clinical condition.

7. Related Codes and Differentiation

Within the Same Category

1A00: Cholera

When to use: For confirmed infections by Vibrio cholerae O1 or O139, characterized by profuse watery diarrhea of sudden onset, "rice water" type, with potentially severe and rapid dehydration, vomiting, and abdominal cramps. Fever is typically absent or minimal.

Main difference vs. 1A07: Cholera manifests as acute gastroenteritis with massive loss of fluids and electrolytes, while typhoid fever is a systemic febrile illness with sustained high fever as a central manifestation. In cholera, the gastrointestinal presentation dominates; in typhoid fever, systemic manifestations are prominent and constipation is more common than diarrhea in adults.

1A01: Intestinal infection by other bacteria of the genus Vibrio

When to use: For infections by Vibrio species other than V. cholerae O1/O139, such as V. parahaemolyticus or V. vulnificus, usually associated with consumption of seafood. They cause acute gastroenteritis, occasionally with skin and soft tissue infections or septicemia in immunosuppressed individuals.

Main difference vs. 1A07: These infections present with acute and self-limited course (days), predominantly gastrointestinal symptoms, and clear epidemiological association with consumption of marine foods. Typhoid fever has prolonged evolution (weeks), sustained high fever, and fecal-oral transmission through contaminated water and food, without specific association with seafood.

1A02: Intestinal infections by Shigella

When to use: For confirmed shigellosis, characterized by acute dysentery with bloody diarrhea containing mucus, intense rectal tenesmus, severe abdominal cramps, and generally moderate fever. The clinical presentation is dominated by lower gastrointestinal symptoms.

Main difference vs. 1A07: Shigellosis presents bloody diarrhea as a cardinal manifestation, with symptoms confined predominantly to the gastrointestinal tract and typical duration of 5-7 days. Typhoid fever is characterized by prolonged high fever, prominent systemic symptoms, constipation more frequent than diarrhea in adults, and clinical course of weeks if untreated.

Differential Diagnoses

Malaria: Can present with high fever, splenomegaly, and systemic symptoms, but typically with intermittent or tertian/quartan fever pattern, not sustained. Differential diagnosis is made by thick blood smear or rapid tests for malaria.

Dengue: Causes high fever of abrupt onset, intense headache, myalgias and arthralgias ("breakbone fever"), but with typical duration of 5-7 days, not weeks. Leukopenia and thrombocytopenia are common, but splenomegaly is rare.

Disseminated tuberculosis: Can cause prolonged fever, weight loss, and splenomegaly, but generally with vespertine fever pattern, profuse night sweats, and pulmonary or other organ manifestations. Diagnosis requires specific microbiological investigation.

8. Differences with ICD-10

Equivalent ICD-10 code: A01.0 (Typhoid fever)

Main changes in ICD-11:

The transition from ICD-10 to ICD-11 maintained typhoid fever as a distinct nosological entity, but with some important structural modifications. In ICD-10, typhoid fever was coded as A01.0, within the A01 grouping that included typhoid and paratyphoid fevers. In ICD-11, code 1A07 maintains specificity for typhoid fever, but the hierarchical structure was reorganized.

ICD-11 offers greater granularity and post-coordination capability, allowing the addition of extensions to specify complications, severity, antimicrobial resistance, and other relevant clinical aspects. This flexibility was not present in ICD-10 in such a structured manner.

The official definition in ICD-11 is more detailed and clinically oriented, specifically including characteristics such as relative bradycardia, typhoid rosettes, and the pattern of constipation versus diarrhea in adults. This facilitates correct coding and reduces ambiguities.

Practical impact:

For healthcare professionals, the transition requires familiarization with the new alphanumeric structure (1A07 versus A01.0), but the essence of the diagnosis remains unchanged. Health information systems need to adequately map old codes to new ones to maintain continuity in epidemiological data. The expanded specification capability in ICD-11 allows for more precise documentation, potentially improving data quality for epidemiological surveillance, research, and clinical management.

9. Frequently Asked Questions

1. How is the definitive diagnosis of typhoid fever made?

Definitive diagnosis requires isolation of Salmonella Typhi through culture of clinical specimens. Blood culture is the gold standard method, with higher positivity in the first week of illness (60-80% of cases). Stool culture and urine culture become more positive after the first week. Bone marrow culture offers greater sensitivity (90%), but is rarely performed due to its invasive nature. Serological tests such as the Widal reaction may assist, but have limitations in sensitivity and specificity, requiring careful interpretation in the clinical-epidemiological context. Molecular methods such as PCR are increasingly available, offering rapid and specific diagnosis.

2. Is treatment available in public health systems?

Yes, treatment of typhoid fever with appropriate antibiotics is widely available in public health systems in many countries. First-line antibiotics include fluoroquinolones (ciprofloxacin), third-generation cephalosporins (ceftriaxone, cefotaxime), and azithromycin. The specific choice depends on local patterns of antimicrobial resistance. In areas with increasing fluoroquinolone resistance, cephalosporins or azithromycin are preferred. Hospitalization may be necessary for severe or complicated cases, but mild cases can be managed on an outpatient basis with appropriate follow-up.

3. How long does treatment last?

The typical duration of antibiotic treatment for uncomplicated typhoid fever is 7 to 14 days, depending on the antibiotic used. Fluoroquinolones are generally administered for 5-7 days in uncomplicated infections caused by susceptible strains. Ceftriaxone is typically administered for 10-14 days. Azithromycin may be used for 5-7 days. Complicated cases or chronic carriers may require longer treatments, sometimes up to 4-6 weeks. Clinical response typically occurs within 3-5 days after initiation of appropriate treatment, with gradual defervescence and symptom improvement.

4. Can this code be used on medical certificates?

Yes, code 1A07 can and should be used on medical certificates when appropriate, especially to justify absence from work or school. Typhoid fever is a notifiable disease in many countries, and patients generally require restriction from activities, especially if they work with food handling or in healthcare services, until control cultures are negative. The period of restriction varies according to local public health regulations, but typically extends until confirmation of bacterial elimination, to prevent transmission.

5. What are the main complications that can occur?

The most serious complications of typhoid fever include intestinal perforation (2-3% of cases, usually in the third week), gastrointestinal hemorrhage (10-20% of cases, ranging from mild to massive), typhoid encephalopathy (confusion, delirium, stupor, seizures), myocarditis, cholecystitis, hepatitis, pneumonia, osteomyelitis, and septic arthritis. Complications are more frequent in untreated patients or those with delayed diagnosis. Intestinal perforation requires urgent surgical intervention and is associated with high mortality if not treated promptly.

6. Is there a vaccine available against typhoid fever?

Yes, vaccines are available against typhoid fever, recommended for travelers to endemic areas and at-risk populations. The main options include the oral attenuated vaccine (Ty21a) and the parenteral Vi capsular polysaccharide vaccine. The oral vaccine requires multiple doses and is not recommended for immunocompromised individuals. The polysaccharide vaccine is administered in a single dose. Both offer moderate protection (50-80% efficacy) for 2-3 years. New conjugate vaccines are being developed and implemented, offering greater efficacy and duration of protection, especially in children.

7. How to differentiate typhoid fever from paratyphoid fever in clinical practice?

Clinically, differentiation between typhoid and paratyphoid fever is difficult, as they present with very similar manifestations. Paratyphoid fever tends to be milder, with shorter duration, fewer complications, and better prognosis, but there is considerable overlap. Definitive distinction requires laboratory identification of the specific Salmonella serotype (Typhi versus Paratyphi A, B, or C). Cultures and molecular methods allow this differentiation. For coding purposes, typhoid fever receives code 1A07, while paratyphoid fever receives code 1A08.

8. Can recovered patients transmit the disease?

Yes, some individuals become chronic carriers after clinical recovery, continuing to shed Salmonella Typhi in feces or urine for prolonged periods (months to years). It is estimated that 1-5% of patients become chronic carriers, defined as persistent excretion for more than one year. Chronic carriers are often asymptomatic but represent an important reservoir for transmission. Colonization generally occurs in the gallbladder. Carriers who work with food or in healthcare services require occupational restrictions and may need prolonged antimicrobial treatment or, in selected cases, cholecystectomy.

Conclusion:

Typhoid fever remains an important global public health problem, especially in regions with inadequate sanitary infrastructure. Correct coding using the ICD-11 code 1A07 is fundamental for epidemiological surveillance, appropriate clinical management, and adequate allocation of health resources. Diagnosis is based on the combination of characteristic clinical presentation, epidemiological context, and laboratory confirmation. Early recognition and appropriate antibiotic treatment significantly reduce the morbidity and mortality associated with this potentially serious disease. Healthcare professionals should maintain a high index of suspicion in patients with prolonged fever, especially those with a history of travel to or exposure to endemic areas, ensuring timely diagnosis, appropriate treatment, and implementation of public health measures to prevent transmission.

External References

This article was prepared based on reliable scientific sources:

References verified on 2026-02-03

Typhoid fever

Compartir